Literature DB >> 6498244

A chronobiological study of melatonin and cortisol secretion in depressed subjects: plasma melatonin, a biochemical marker in major depression.

B Claustrat, G Chazot, J Brun, D Jordan, G Sassolas.   

Abstract

The temporal organization of plasma melatonin and cortisol secretion was examined in healthy rested controls and in depressed patients: 11 patients suffering from a primary affective disorder (10 female, 1 male) and 8 male controls were studied over a 24-hr period; blood was collected at 2-hr intervals during the day at 1-hr intervals at night. Plasma melatonin and cortisol levels were determined by radioimmunoassay. In addition, melatonin was determined in plasma sampled at 3 AM in older male controls (n = 8) and in females (n = 10) at ovulation. The controls showed low or undetectable (less than 5 pg/ml) diurnal plasma melatonin levels and a very marked nocturnal rhythm (acrophase: 2.27 AM, mesor: 34.4 pg/ml, amplitude: 58.7 pg/ml). For the three control groups, no significant difference was observed in the nocturnal melatonin peak at 3 AM. The depressed patients also showed a significant melatonin rhythm but with lower amplitude (14.5 pg/ml) and mesor (19.1 pg/ml). The latter rhythm was not significantly phase-advanced with respect to the controls (acrophase at 1.18 and 2.34 AM, respectively). In 9 of the 11 patients, nocturnal melatonin secretion was less marked and frequently associated with hypercortisolemia. An additional episodic melatonin secretion was observed in the late afternoon in only two patients. In depressed patients, there was an increase in the mean cortisol secretion level (mesor at 13.6 micrograms/100 ml against 9.1 micrograms/100 ml in the controls), but the amplitude and the acrophase were not significantly modified. These data are discussed in terms of both the hypothalamus-pituitary-adrenal-epiphysis and aminergic abnormalities.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6498244

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  32 in total

1.  Age, alcoholism and depression are associated with low levels of urinary melatonin.

Authors:  L Wetterberg; B Aperia; D A Gorelick; H E Gwirtzman; M T McGuire; E A Serafetinides; A Yuwiler
Journal:  J Psychiatry Neurosci       Date:  1992-11       Impact factor: 6.186

2.  Influence of the time of administration of dexamethasone 0.25 mg on cortisol secretion in normal humans.

Authors:  P Schulz; C Costa; J Widmer; P Dick
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

3.  Marked enhancement by clorgyline of nocturnal and daytime melatonin release in rhesus monkeys.

Authors:  D L Murphy; N A Garrick; J L Hill; L Tamarkin
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

4.  Effects of electromagnetic fields exposure on plasma hormonal and inflammatory pathway biomarkers in male workers of a power plant.

Authors:  Zhaopin Wang; Ying Fei; Hui Liu; Shuangshuang Zheng; Zheyuan Ding; Wen Jin; Yifeng Pan; Zexin Chen; Lijuan Wang; Guangdi Chen; Zhengping Xu; Yongjian Zhu; Yunxian Yu
Journal:  Int Arch Occup Environ Health       Date:  2015-03-26       Impact factor: 3.015

5.  Altered sleep architecture and higher incidence of subsyndromal depression in low endogenous melatonin secretors.

Authors:  Shadab Ataur Rahman; Shai Marcu; Leonid Kayumov; Colin Michael Shapiro
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2009-12-18       Impact factor: 5.270

6.  Pharmacokinetics of melatonin in man after intravenous infusion and bolus injection.

Authors:  C Mallo; R Zaĭdan; G Galy; E Vermeulen; J Brun; G Chazot; B Claustrat
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

7.  A dietary supplement to improve the quality of sleep: a randomized placebo controlled trial.

Authors:  Catherine Cornu; Laurent Remontet; Florence Noel-Baron; Alain Nicolas; Nathalie Feugier-Favier; Pascal Roy; Bruno Claustrat; Mitra Saadatian-Elahi; Behrouz Kassaï
Journal:  BMC Complement Altern Med       Date:  2010-06-22       Impact factor: 3.659

Review 8.  Clinical aspects of the melatonin action: impact of development, aging, and puberty, involvement of melatonin in psychiatric disease and importance of neuroimmunoendocrine interactions.

Authors:  F Waldhauser; B Ehrhart; E Förster
Journal:  Experientia       Date:  1993-08-15

Review 9.  Circadian rhythm disturbances in depression.

Authors:  Anne Germain; David J Kupfer
Journal:  Hum Psychopharmacol       Date:  2008-10       Impact factor: 1.672

10.  Increased melatonin and delayed offset in menopausal depression: role of years past menopause, follicle-stimulating hormone, sleep end time, and body mass index.

Authors:  Barbara L Parry; Charles J Meliska; Diane L Sorenson; Ana M López; Luis F Martínez; Sara Nowakowski; Richard L Hauger; Jeffrey A Elliott
Journal:  J Clin Endocrinol Metab       Date:  2007-11-27       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.